Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients

被引:114
|
作者
Sale, J. E. M. [1 ,2 ]
Beaton, D. [1 ,2 ]
Posen, J. [2 ]
Elliot-Gibson, V. [2 ]
Bogoch, E. [3 ]
机构
[1] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
[2] St Michaels Hosp, Mobil Program, Keenan Res Ctr, Clin Res Unit,Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
[3] Univ Toronto, Dept Surg, Toronto, ON, Canada
关键词
Fragility fracture; Investigation; Osteoporosis; Systematic review; Treatment; RANDOMIZED CONTROLLED-TRIAL; CLINICAL-PRACTICE GUIDELINES; DISTAL FOREARM FRACTURE; BONE-MINERAL DENSITY; HIP FRACTURE; POSTMENOPAUSAL WOMEN; DISEASE-MANAGEMENT; LIAISON SERVICE; RISK-FACTORS; MULTIFACETED INTERVENTION;
D O I
10.1007/s00198-011-1544-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aims to determine osteoporosis (OP) investigation and treatment within post-fracture initiatives conducted in fracture clinics and other orthopedic environments. A systematic review was conducted. Eligibility criteria were: hip fracture patients plus all other fracture patients presenting with a fragility fracture, orthopedic setting where orthopedic physicians/staff were involved, intervention to improve OP management, primary data on a parts per thousand yen20 patients from randomized controlled trials (RCTs) and other study designs. We calculated outcome data within 6 months of screening from an intention-to-treat principle to derive an equated proportion (EP) across interventions. Outcomes were: (1) proportion of patients investigated with bone densitometry, (2) proportion of patients initiating OP medication, and (3) proportion of patients taking OP medication. We identified 2,259 citations, of which 57 articles that included 64 intervention groups were eligible. The median EP for patients investigated was 43% and the 75th percentile was 71%. The median EP for medication initiation was 22% and the 75th percentile was 34%. The median EP for medication taking was 27.5% and the 75th percentile was 43%. The EPs for all outcomes were higher for interventions with dedicated personnel to implement the intervention and those within which bone mineral density testing and/or treatment were included. In studies with an EP, up to 71% of patients were investigated for OP, but < 35% initiated medication, and < 45% were taking medication within 6 months of screening. Calculating an EP allowed us to compare outcomes across the studies, therefore capturing both RCTs and other study designs typical of real-world settings.
引用
收藏
页码:2067 / 2082
页数:16
相关论文
共 50 条
  • [41] Pharmacist interventions in osteoporosis management: a systematic review
    Laird, Catherine
    Benson, Helen
    Williams, Kylie A.
    OSTEOPOROSIS INTERNATIONAL, 2023, 34 (02) : 239 - 254
  • [42] Prevalence of and risk factors for osteoporosis and fragility fracture in adults with cerebral palsy: A systematic review
    Trinh, Anne
    Fremion, Ellen
    Bhathena, Shayan
    Munns, Craig F.
    Morgan, Prue
    Whitney, Daniel G.
    Gillick, Bernadette
    Zacharin, Margaret
    Fehlings, Darcy
    Vincent, Amanda J.
    Milat, Frances
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2025,
  • [43] Pharmacist interventions in osteoporosis management: a systematic review
    Catherine Laird
    Helen Benson
    Kylie A. Williams
    Osteoporosis International, 2023, 34 : 239 - 254
  • [44] OFELIA: Prevalence of Osteoporosis in Fragility Fracture Patients
    Randi M. H. Tei
    Cecilia H. Ramlau-Hansen
    Oleguer Plana-Ripoll
    Ole Brink
    Bente L. Langdahl
    Calcified Tissue International, 2019, 104 : 102 - 114
  • [45] Do patients perceive a link between a fragility fracture and osteoporosis?
    Lora Giangregorio
    Alexandra Papaioannou
    Lehana Thabane
    Justin deBeer
    Ann Cranney
    Lisa Dolovich
    Anthony Adili
    Jonathan D Adachi
    BMC Musculoskeletal Disorders, 9
  • [46] Influence of bone densitometry on the anti-osteoporosis treatment after fragility hip fracture
    Peiwen Wang
    Yizhong Li
    Huafeng Zhuang
    Haiming Yu
    Siqing Cai
    Hao Xu
    Zhenhui Chen
    Jinkuang Lin
    Xuedong Yao
    Aging Clinical and Experimental Research, 2019, 31 : 1525 - 1529
  • [47] The effects of osteoporosis education program for patients with fragility fracture in China
    She, Pan
    Huang, Chun
    Peng, Lingli
    Yang, Jiaqi
    Wang, Ling
    Liu, Qingqing
    Tang, Hongying
    INTERNATIONAL JOURNAL OF ORTHOPAEDIC AND TRAUMA NURSING, 2024, 52
  • [48] Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review
    Grace Raybould
    Opeyemi Babatunde
    Amy L. Evans
    Joanne L. Jordan
    Zoe Paskins
    Archives of Osteoporosis, 2018, 13
  • [49] Influence of bone densitometry on the anti-osteoporosis treatment after fragility hip fracture
    Wang, Peiwen
    Li, Yizhong
    Zhuang, Huafeng
    Yu, Haiming
    Cai, Siqing
    Xu, Hao
    Chen, Zhenhui
    Lin, Jinkuang
    Yao, Xuedong
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 31 (10) : 1525 - 1529
  • [50] A systematic review of interventions by healthcare professionals on community-dwelling postmenopausal women with osteoporosis
    Lai, P.
    Chua, S. S.
    Chan, S. P.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (10) : 1637 - 1656